Leslie Nangle Greene

Title: The Innovations of Leslie Nangle Greene

Introduction

Leslie Nangle Greene is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compositions targeting neuropilin-2 (NRP2). With a total of two patents to his name, his work has the potential to impact the treatment of various diseases.

Latest Patents

Leslie's latest patents focus on compositions and methods comprising anti-NRP2 antibodies. These patents provide antibodies and antigen-binding fragments that specifically bind to human neuropilin-2 polypeptides. They modulate binding interactions between human NRP2 and at least one NRP2 ligand, such as human histidyl-tRNA synthetase (HRS). This modulation can influence downstream signaling events mediated by NRP2, leading to therapeutic applications for treating NRP2-associated diseases.

Career Highlights

Leslie Nangle Greene is currently associated with Atyr Pharma, Inc., where he continues to advance his research and innovations. His work is pivotal in the development of new therapeutic strategies that leverage the unique properties of NRP2.

Collaborations

Leslie collaborates with talented individuals such as Luke Burman and Yee Ting (Esther) Chong, who contribute to the innovative environment at Atyr Pharma, Inc. Their combined expertise fosters a collaborative atmosphere that enhances the potential for groundbreaking discoveries.

Conclusion

Leslie Nangle Greene's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work on anti-NRP2 antibodies represents a significant advancement in therapeutic approaches for treating diseases associated with NRP2.